user

Commentary on Austrian consensus paper on prophylaxis of the RSV-Infection with palivizumab and Post-RSV-respiratory-diseases

被引：1
|
作者：
Liese, J. [1 ]
机构：
[1] Univ Munich, Abt Antimikrobielle Tehrapie & Infekt Immunol, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany
来源：
MONATSSCHRIFT KINDERHEILKUNDE | 2008年 / 156卷 / 04期
关键词：
D O I：
10.1007/s00112-008-1744-5
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：384 / 384
页数：1
相关论文
共 50 条
  • [21] Emotional and time costs of respiratory syncytial virus prophylaxis: Comparing palivizumab to RSV-IG
    Robbins, JM
    Tilford, JM
    Gillaspy, SR
    Simpson, DD
    Wheeler, JG
    Shaw, JL
    Jacobs, RF
    PEDIATRIC RESEARCH, 2000, 47 (04) : 221A - 221A
  • [22] An outpatient program for administration of palivizumab prophylaxis for respiratory syncitial virus (RSV) in a subacute pediatric hospital
    Gonzalez, F
    Ballard, D
    Hirsch, D
    PEDIATRIC RESEARCH, 2002, 51 (04) : 218A - 218A
  • [23] Respiratory Disorders and Hospitalization Rates During the Second RSV Season in Preterm Infants Who Received Palivizumab Prophylaxis During Their First RSV Season
    Fanos, V.
    Scarcella, A.
    Puddu, M.
    Gallini, F.
    Tuminelli, F.
    Bragetti, P.
    Gallina, M. R.
    Quartulli, L.
    Benincori, N.
    Citro, G.
    Via, L. Dalla
    Barera, G.
    Paparatti, U. Di Luzio
    Merolla, R.
    Romano, G. V.
    Guida, G.
    Silvestri, M.
    Rossi, G. A.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (03) : 302 - 310
  • [24] CHILDREN HOSPITALIZED WITH RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION AFTER PALIVIZUMAB PROPHYLAXIS IN TWO LARGE PAEDIATRIC TERTIARY CARE CENTERS
    Rajakumar, D.
    Tan, B.
    Bodani, J.
    Zhu, T.
    Janzen, B.
    Bodani, R.
    Kurji, A.
    Sharma, A.
    McConnell, A.
    Kalapurackal, M.
    Sankaran, K.
    ACTA PAEDIATRICA, 2009, 98 : 214 - 215
  • [25] Efficacy and Safety of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Disease: An Updated Systemic Review and MetaAnalysis
    El-Atawi, Khaled
    De Luca, Daniele
    Ramanathan, Ranagasamy
    Luna, Manuel Sanchez
    Alsaedi, Saad
    Wahab, Muzafar Gani Abdul
    Hamdi, Moataz
    Saleh, Maysa
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [26] Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
    Antepowicz, A.
    Kirsebom, F.
    Johansson, C.
    Gill, D. R.
    Hyde, S. C.
    HUMAN GENE THERAPY, 2018, 29 (12) : A118 - A118
  • [27] Palivizumab prophylaxis in patients admitted to the pediatric intensive care unit (PICU) with respiratory syncytial virus (RSV).
    Feller, AE
    Morrison, WE
    Straumanis, JP
    CRITICAL CARE MEDICINE, 2005, 33 (12) : A92 - A92
  • [28] Seasonal respiratory syncytial virus (RSV) infection post-immune prophylaxis: Compliance and patient characteristics
    Imaizumi, S
    DeLauter, M
    Pereira, GR
    Hurt, H
    Fernandes, M
    Goldsmith, L
    PEDIATRIC RESEARCH, 2000, 47 (04) : 341A - 341A
  • [29] Palivizumab for prophylaxis of RSV infection: five epidemic seasons' experience on adverse effects (2002-2007)
    Parmigiani, Stefano
    Pezzoni, Silvia
    Solari, Elena
    Arena, Vittoria
    De Martino, Arianna
    Alessandrini, Cristina
    Moretti, Sabrina
    Bevilacqua, Giulio
    JOURNAL OF PERINATAL MEDICINE, 2009, 37 (03) : 304 - 305
  • [30] Leitlinie zur Prophylaxe von schweren RSV-Erkrankungen bei Risikokindern mit PalivizumabStatement on the prophylaxis of severe RSV diseases using palivizumab in at risk children
    Monatsschrift Kinderheilkunde, 2007, 155 (7) : 649 - 652
12345